Balance Medical announced on September 30 that as of September 29, 2026, the company had repurchased 1.3 million shares, accounting for 0.9428% of total share capital, with a repurchase amount of 99.99 million yuan and a repurchase price range of 67.76 yuan to 85.45 yuan per share. In the first half of 2026, Balance Medical achieved revenue of 254 million yuan and net profit attributable to the parent of 43.89 million yuan.
Beijing Balance Medical Technology Co LtdBalance Medical repurchased 1.3 million shares for 99.99 million yuan, a buyback that is a capital/valuation event.
